Location: Home
  • search
  • go
  • Relate News
  • 12/13/2024Recent Executive Moves
  • 12/12/2024Shanghai Unveils RMB10 Billion Biopharma M&A Fund to Drive Industry Gr...
  • 12/12/2024Bayer Co.Lab Expands in China with Three New Biotech Partners
  • 12/12/2024Chinese Generic Drug Market Expected to Rise at 10.70% CAGR During 202...
  • 12/12/2024JPO Publicizes the Proposed Results of the 10th National VBP
  • 12/11/2024South China Public Hospitals Slash Salaries Amid Mounting Financial Pr...
  • 12/11/2024Santhera Wins First Chinese Approval for Duchenne Muscular Dystrophy ...
  • 12/10/2024The Proposed BIOSECURE Act Faces Setback in Senate
  • 12/10/2024NHSA and NHC Jointly Issue New Policy Document on Centralized Drug Pro...
  • 12/10/2024Abbisko Reports Promising Preliminary Phase 2 Data for Pimicotinib in ...
  • 12/10/2024Loncastuximab Tesirine Gains Approval in China for 3L r/r DLBCL Treatm...
  • 12/10/2024Merck's Keytruda Gains First Approval in China for Cervical Cancer Tre...
  • 12/10/2024Sperogenix's Vamorolone Approved in China for DMD
  • 12/10/2024China Biopharma CDMOs Win Reprieve as Biosecure Act Omitted from US De...
  • 12/10/2024Beijing Hanmi Launches $98.65M Expansion Project Near Capital Airport
  • 12/10/2024China Biopharma Tracker – November 2024 (PharmaDJ)
  • 12/10/2024How Wholly Foreign-Owned Hospitals Can Help China's Health Care Sector...
  • 12/10/2024The New Draft Administrative Measures For Management Of Medical Repres...
  • 12/9/2024Belief Biomed Unveils Promising Gene Therapy Data at ASH 2024
  • 12/6/2024Medical Costs in Mainland China and Hong Kong to Grow More Slowly Than...
  • 12/6/2024CDE Seeks Comments on Draft ICH Guidelines M15
  • 12/6/2024Recent Executive Moves
  • 12/5/2024SK Biopharm Advances Epilepsy Treatment in China with NDA Submission ...
  • 12/5/20242025 Trends Buoying Boom Phase in APAC (Biospectrum)
  • 12/5/2024Big Pharma Doubles Down on China (The Wire China)
  • 12/3/2024Big Pharma's Bet on China Biotech Is a Rare Trade Bright Spot (Bloomb...
  • 12/3/2024CMS Gains Licenses Class 1 New Drug Targeting Gout and Hyperuricemia f...
  • 12/3/2024Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
  • 12/3/2024NHC Minister Meets with Sanofi and BioMérieux Bosses to Strengthen Si...
  • 12/3/2024PharmaMar/Luye's Lurbinectedin Gains Approval in China for Treating Me...
  • Page:13/356 Total number of articles:10656: [First][<<] [11] [12] [13] [14] [15] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group